Shimadzu adds color-flow systems

Article

Shimadzu Medical Systems grew its product line at the 1999 RSNA meeting with the introductions of SDU-2200, a general-purpose ultrasound scanner, and SDU-1200, a special-purpose scanner.SDU-1200 is targeted for radiology/abdominal, vascular, ob/gyn,

Shimadzu Medical Systems grew its product line at the 1999 RSNA meeting with the introductions of SDU-2200, a general-purpose ultrasound scanner, and SDU-1200, a special-purpose scanner.

SDU-1200 is targeted for radiology/abdominal, vascular, ob/gyn, urology, and breast imaging applications. The works-in-progress scanners are the first color systems Shimadzu will bring to the U.S. marketplace.

SDU-2200 includes a 64-channel, quad-receive digital beamformer, while SDU-1200 employs a 48-channel, dual-receive digital beamformer. Both systems are equipped with color and power Doppler capabilities.

Equipped with convex and linear probes, SDU-1200 will cost approximately $65,000. SDU-2200, including convex, linear, and sector probes, will cost approximately $80,000. The Torrance, CA-based vendor hopes to begin shipments in May, pending Food and Drug Administration 510(k) clearance.

In future upgrade plans, Shimadzu plans to add harmonic imaging for SDU-2200 and 3-D capability for both SDU-2200 and SDU-1200. These features are expected to be available by the third quarter of next year.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.